-
1
-
-
79956110354
-
Importance of local hemodynamic conditions in the atherosclerotic effect of increased heart rate
-
Chatzizisis, Y.S.; Giannoglou, G.D. Importance of local hemodynamic conditions in the atherosclerotic effect of increased heart rate. J. Am. Coll. Cardiol. 2011, 57, 2206.
-
(2011)
J. Am. Coll. Cardiol.
, vol.57
, pp. 2206
-
-
Chatzizisis, Y.S.1
Giannoglou, G.D.2
-
2
-
-
67650141667
-
Heart rate as a risk factor for cardiovascular disease
-
Perret-Guillaume, C.; Joly, L.; Benetos, A. Heart rate as a risk factor for cardiovascular disease. Prog. Cardiovasc. Dis. 2009, 52, 6-10.
-
(2009)
Prog. Cardiovasc. Dis.
, vol.52
, pp. 6-10
-
-
Perret-Guillaume, C.1
Joly, L.2
Benetos, A.3
-
3
-
-
79551516838
-
Heart rate reduction in cardiovascular disease and therapy
-
Reil, J.C.; Custodis, F.; Swedberg, K.; Komajda, M.; Borer, J.S.; Ford, I.; Tavazzi, L.; Laufs, U.; Böhm, M. Heart rate reduction in cardiovascular disease and therapy. Clin. Res. Cardiol. 2011, 100, 11-19.
-
(2011)
Clin. Res. Cardiol.
, vol.100
, pp. 11-19
-
-
Reil, J.C.1
Custodis, F.2
Swedberg, K.3
Komajda, M.4
Borer, J.S.5
Ford, I.6
Tavazzi, L.7
Laufs, U.8
Böhm, M.9
-
4
-
-
84861486321
-
Increased heart rate and atherosclerosis: Potential implications of ivabradine therapy
-
Dominguez-Rodriguez, A.; Blanco-Palacios, G.; Abreu-Gonzalez, P. Increased heart rate and atherosclerosis: potential implications of ivabradine therapy. World J. Cardiol. 2011, 3, 101-104.
-
(2011)
World J. Cardiol.
, vol.3
, pp. 101-104
-
-
Dominguez-Rodriguez, A.1
Blanco-Palacios, G.2
Abreu-Gonzalez, P.3
-
5
-
-
0345866810
-
Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs
-
Colin, P.; Ghaleh, B.; Monnet, X.; Hittinger, L.; Berdeaux, A. Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs. J. Pharmacol. Exp. Ther. 2004, 308, 236-240.
-
(2004)
J. Pharmacol. Exp. Ther.
, vol.308
, pp. 236-240
-
-
Colin, P.1
Ghaleh, B.2
Monnet, X.3
Hittinger, L.4
Berdeaux, A.5
-
6
-
-
67650118795
-
Elevated heart rate in cardiovascular diseases: A target for treatment?
-
Palatini, P. Elevated heart rate in cardiovascular diseases: A target for treatment? Prog. Cardiovasc. Dis. 2009, 52, 46-60.
-
(2009)
Prog. Cardiovasc. Dis.
, vol.52
, pp. 46-60
-
-
Palatini, P.1
-
7
-
-
0027530224
-
Pacemaker mechanisms in cardiac tissue
-
DiFrancesco, D. Pacemaker mechanisms in cardiac tissue. Annu. Rev. Physiol. 1993, 55, 451-467.
-
(1993)
Annu. Rev. Physiol.
, vol.55
, pp. 451-467
-
-
DiFrancesco, D.1
-
8
-
-
0018387132
-
How does adrenaline accelerate the heart?
-
Brown, H.F.; Di Francesco, D.; Noble, S.J. How does adrenaline accelerate the heart? Nature 1979, 280, 235-236.
-
(1979)
Nature
, vol.280
, pp. 235-236
-
-
Brown, H.F.1
Di Francesco, D.2
Noble, S.J.3
-
9
-
-
0019229267
-
Voltage-clamp investigations of membrane currents underlying pacemaker activity in rabbit sino- atrial node
-
Brown, H.F.; DiFrancesco, D. Voltage-clamp investigations of membrane currents underlying pacemaker activity in rabbit sino- atrial node. J. Physiol. 1980, 308, 331-351.
-
(1980)
J. Physiol.
, vol.308
, pp. 331-351
-
-
Brown, H.F.1
DiFrancesco, D.2
-
10
-
-
0025782740
-
Direct activation of cardiac pacemaker channels by intracellular cyclic amp
-
DiFrancesco, D.; Tortora, P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 1991, 351, 145-147.
-
(1991)
Nature
, vol.351
, pp. 145-147
-
-
DiFrancesco, D.1
Tortora, P.2
-
11
-
-
0032508040
-
A family of hyperpolarizationactivated mammalian cation channels
-
Ludwig, A.; Zong, X.; Jeglitsch, M.; Hofmann, F.; Biel, M. A family of hyperpolarizationactivated mammalian cation channels. Nature 1998, 393, 587-591.
-
(1998)
Nature
, vol.393
, pp. 587-591
-
-
Ludwig, A.1
Zong, X.2
Jeglitsch, M.3
Hofmann, F.4
Biel, M.5
-
12
-
-
0032577559
-
Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain
-
Santoro, B.; Liu, D.T.; Yao, H.; Bartsch, D.; Kandel, E.R.; Siegelbaum, S.A.; Tibbs, G.R. Identification of a gene encoding a hyperpolarization- activated pacemaker channel of brain. Cell 1998, 93, 717-729.
-
(1998)
Cell
, vol.93
, pp. 717-729
-
-
Santoro, B.1
Liu, D.T.2
Yao, H.3
Bartsch, D.4
Kandel, E.R.5
Siegelbaum, S.A.6
Tibbs, G.R.7
-
13
-
-
0033165606
-
Structure and function of cardiac pacemaker channels
-
Ludwig, A.; Zong, X.; Hofmann, F.; Biel, M. Structure and function of cardiac pacemaker channels. Cell. Physiol. Biochem. 1999, 9, 179-186.
-
(1999)
Cell. Physiol. Biochem.
, vol.9
, pp. 179-186
-
-
Ludwig, A.1
Zong, X.2
Hofmann, F.3
Biel, M.4
-
14
-
-
0035794167
-
Functional heteromerization of hcn1 and hcn2 pacemaker channels
-
Ulens, C.; Tytgat, J. Functional heteromerization of HCN1 and HCN2 pacemaker channels. J. Biol. Chem. 2001, 276, 6069-6072.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 6069-6072
-
-
Ulens, C.1
Tytgat, J.2
-
15
-
-
0242353179
-
Role of subunit heteromerization and n-linked glycosylation in the formation of functional hyperpolarization-activated cyclic nucleotide-gated channels
-
Much, B.; Wahl-Schott, C.; Zong, X.; Schneider, A.; Baumann, L.; Moosmang, S.; Ludwig, A.; Biel, M. Role of subunit heteromerization and N-linked glycosylation in the formation of functional hyperpolarization-activated cyclic nucleotide-gated channels. J. Biol. Chem. 2003, 278, 43781-43786.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 43781-43786
-
-
Much, B.1
Wahl-Schott, C.2
Zong, X.3
Schneider, A.4
Baumann, L.5
Moosmang, S.6
Ludwig, A.7
Biel, M.8
-
16
-
-
17444429283
-
Formation of heteromeric hyperpolarization-activated cyclic nucleotide-gated (hcn) channels in the hippocampus is regulated by developmental seizures
-
Brewster, A.L.; Bernard, J.A.; Gall, C.M.; Baram, T.Z. Formation of heteromeric hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in the hippocampus is regulated by developmental seizures. Neurobiol. Dis. 2005, 19, 200-207.
-
(2005)
Neurobiol. Dis.
, vol.19
, pp. 200-207
-
-
Brewster, A.L.1
Bernard, J.A.2
Gall, C.M.3
Baram, T.Z.4
-
18
-
-
79955521396
-
Comparison of the effects of ivabradine and atenolol on heart rate and echocardiographic variables of left heart function in healthy cats
-
Riesen, S.C.; Schober, K.E.; Cervenec, R.M.; Bonagura, J.D. Comparison of the effects of ivabradine and atenolol on heart rate and echocardiographic variables of left heart function in healthy cats. J. Vet. Intern. Med. 2011, 25, 469-476.
-
(2011)
J. Vet. Intern. Med.
, vol.25
, pp. 469-476
-
-
Riesen, S.C.1
Schober, K.E.2
Cervenec, R.M.3
Bonagura, J.D.4
-
19
-
-
78149400043
-
Beta-blockers Focus on mechanism of action. Which beta-blocker, when and why?
-
Gorre, F.; Vandekerckhove, H. Beta-blockers: Focus on mechanism of action. Which beta-blocker, when and why? Acta Cardiol. 2010, 65, 565-570.
-
(2010)
Acta Cardiol.
, vol.65
, pp. 565-570
-
-
Gorre, F.1
Vandekerckhove, H.2
-
20
-
-
0028910325
-
Cardiac electrophysiologic effects of alinidine, a specific bradycardic agent, in the conscious dog: Plasma concentration-response relations
-
Boucher, M.; Chassaing, C.; Chapuy, E. Cardiac electrophysiologic effects of alinidine, a specific bradycardic agent, in the conscious dog: Plasma concentration-response relations. J. Cardiovasc. Pharmacol. 1995, 25, 229-233.
-
(1995)
J. Cardiovasc. Pharmacol.
, vol.25
, pp. 229-233
-
-
Boucher, M.1
Chassaing, C.2
Chapuy, E.3
-
21
-
-
0142138310
-
Use-dependent blockade of cardiac pacemaker current (if) by cilobradine and zatebradine
-
van Bogaert, P.P.; Pittoors, F. Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine. Eur. J. Pharmacol. 2003, 478, 161-171.
-
(2003)
Eur. J. Pharmacol.
, vol.478
, pp. 161-171
-
-
Van Bogaert, P.P.1
Pittoors, F.2
-
22
-
-
60849133375
-
Effects of intrathecal injection of a hyperpolarization-activated channel (ih) inhibitor zd7288 on bladder function in urethane-anesthetized rats
-
Masuda, N.; Masuda, H.; Matsuyoshi, H.; Chancellor, M.B.; de Groat, W.C.; Yoshimura, N. Effects of intrathecal injection of a hyperpolarization-activated channel (Ih) inhibitor ZD7288 on bladder function in urethane-anesthetized rats. Neurourol. Urodyn. 2008, 27, 838-844.
-
(2008)
Neurourol. Urodyn.
, vol.27
, pp. 838-844
-
-
Masuda, N.1
Masuda, H.2
Matsuyoshi, H.3
Chancellor, M.B.4
De Groat, W.C.5
Yoshimura, N.6
-
23
-
-
31144438644
-
The discovery of the selective if current inhibitor ivabradine (procoralan): A new therapeutic approach to ischemic heart disease
-
Vilaine, J.P. The discovery of the selective if current inhibitor ivabradine (Procoralan): A new therapeutic approach to ischemic heart disease. Med. Sci. (Paris) 2006, 22, 87-94.
-
(2006)
Med. Sci. (Paris
, vol.22
, pp. 87-94
-
-
Vilaine, J.P.1
-
24
-
-
11144229155
-
Selection and pharmacological characterisation of procoralan, a selective inhibitor of the pacemaker if current
-
Vilaine, J.P. Selection and pharmacological characterisation of Procoralan, a selective inhibitor of the pacemaker if current. Therapie 2004, 59, 495-505.
-
(2004)
Therapie
, vol.59
, pp. 495-505
-
-
Vilaine, J.P.1
-
25
-
-
83055194585
-
Efficacy of ivabradine in combination with beta-blocker versus uptitration of beta-blocker in patients with stable angina
-
Amosova, E.; Andrejev, E.; Zaderey, I.; Rudenko, U.; Ceconi, C.; Ferrari, R. Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina. Cardiovasc. Drugs. Ther. 2011, 25, 531-537.
-
(2011)
Cardiovasc. Drugs. Ther.
, vol.25
, pp. 531-537
-
-
Amosova, E.1
Andrejev, E.2
Zaderey, I.3
Rudenko, U.4
Ceconi, C.5
Ferrari, R.6
-
26
-
-
34248325329
-
Ivabradine: New drug. Best avoided in stable angina
-
Anonymous
-
Anonymous. Ivabradine: New drug. Best avoided in stable angina. Prescrire Int. 2007, 16,53-56.
-
(2007)
Prescrire Int.
, vol.16
, pp. 53-56
-
-
-
27
-
-
77956612624
-
Ivabradine and outcomes in chronic heart failure (shift): A randomised placebo-controlled study
-
Swedberg, K.; Komajda, M.; Bohm, M. Ivabradine and outcomes in chronic heart failure (shift): A randomised placebo-controlled study. Lancet 2010, 376, 875-885.
-
(2010)
Lancet
, vol.376
, pp. 875-885
-
-
Swedberg, K.1
Komajda, M.2
Bohm, M.3
-
28
-
-
77949379565
-
A step further with ivabradine: Signify (study assessing the morbidity-mortality benefits of the if inhibitor ivabradine in patients with coronary artery disease
-
Ferrari, R. A step further with ivabradine: Signify (study assessing the morbidity-mortality benefits of the If inhibitor ivabradine in patients with coronary artery disease). Eur. Heart. J. Suppl. 2009, 11 (Suppl. D), D19-D27.
-
(2009)
Eur. Heart. J. Suppl.
, vol.11
, Issue.SUPPL.. D
-
-
Ferrari, R.1
-
29
-
-
20444457018
-
Drug insight: If inhibitors as specific heart-rate-reducing agents
-
Borer, J.S. Drug insight: If inhibitors as specific heart-rate-reducing agents. Nat. Clin. Pract. Cardiovasc. Med. 2004, 1, 103-109.
-
(2004)
Nat. Clin. Pract. Cardiovasc. Med.
, vol.1
, pp. 103-109
-
-
Borer, J.S.1
-
30
-
-
84861494804
-
Adjuvant use of ivabradine in acute heart failure due to myocarditis
-
Franke, J.; Schmahl, D.; Lehrke, S.; Pribe, R.; Bekeredjian, R.; Doesch, A.O.; Ehlermann, P.; Schnabel, P.; Katus, H.A.; Zugck, C. Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis. Case Rep. Med. 2011, 2011, 203690.
-
(2011)
Case Rep. Med.
, vol.2011
, pp. 203690
-
-
Franke, J.1
Schmahl, D.2
Lehrke, S.3
Pribe, R.4
Bekeredjian, R.5
Doesch, A.O.6
Ehlermann, P.7
Schnabel, P.8
Katus, H.A.9
Zugck, C.10
-
31
-
-
59249108973
-
Ivabradine Pharmacodynamic aspects of its clinical use
-
Stieber, J. Ivabradine: Pharmacodynamic aspects of its clinical use. Methods Find. Exp. Clin. Pharmacol. 2008, 30, 633-641.
-
(2008)
Methods Find. Exp. Clin. Pharmacol.
, vol.30
, pp. 633-641
-
-
Stieber, J.1
-
32
-
-
4944222848
-
Efficacy and safety of a metabolic modulator drug in chronic stable angina: Review of evidence from clinical trials
-
Chaitman, B.R. Efficacy and safety of a metabolic modulator drug in chronic stable angina: Review of evidence from clinical trials. J. Cardiovasc. Pharmacol. Ther. 2004, 1, S47-S64.
-
(2004)
J. Cardiovasc. Pharmacol. Ther.
, vol.1
-
-
Chaitman, B.R.1
-
33
-
-
4544344025
-
Heart rate lowering by specific and selective if current inhibition with ivabradine
-
Di Francesco, D.; Camm, A.J. Heart rate lowering by specific and selective If current inhibition with ivabradine. Drugs 2004, 64, 1757-1765.
-
(2004)
Drugs
, vol.64
, pp. 1757-1765
-
-
Di Francesco, D.1
Camm, A.J.2
-
34
-
-
80054742115
-
Shift investigators. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: Results from the shift echocardiography substudy
-
Tardif, J.C.; O'Meara, E.; Komajda, M.; Böhm, M.; Borer, J.S.; Ford, I.; Tavazzi, L.; Swedberg, K. SHIFT Investigators. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: Results from the SHIFT echocardiography substudy. Eur. Heart J. 2011, 32, 2507-2515.
-
(2011)
Eur. Heart J.
, vol.32
, pp. 2507-2515
-
-
Tardif, J.C.1
O'Meara, E.2
Komajda, M.3
Böhm, M.4
Borer, J.S.5
Ford, I.6
Tavazzi, L.7
Swedberg, K.8
-
35
-
-
11144356194
-
Long-term heart rate reduction induced by the selective i(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure
-
Mulder, P.; Barbier, S.; Chagraoui, A.; Richard, V.; Henry, J.P.; Lallemand, F.; Renet, S.; Lerebours, G.; Mahlberg-Gaudin, F.; Thuillez, C. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 2004, 109, 1674-1679.
-
(2004)
Circulation
, vol.109
, pp. 1674-1679
-
-
Mulder, P.1
Barbier, S.2
Chagraoui, A.3
Richard, V.4
Henry, J.P.5
Lallemand, F.6
Renet, S.7
Lerebours, G.8
Mahlberg-Gaudin, F.9
Thuillez, C.10
-
36
-
-
65549128780
-
Ivabradine: Cardiovascular effects
-
Rognoni, A.; Bertolazzi, M.; Macciò, S.; Rognoni, G. Ivabradine: cardiovascular effects. Cardiovasc. Drug. Discov. 2009, 4, 61-66.
-
(2009)
Cardiovasc. Drug. Discov.
, vol.4
, pp. 61-66
-
-
Rognoni, A.1
Bertolazzi, M.2
Macciò, S.3
Rognoni, G.4
-
37
-
-
0037305154
-
Contributions of heart rate and contractility to myocardial oxygen balance during exercise
-
Colin, P.; Ghaleh, B.; Monnet, X.; Su, J.; Hittinger, L.; Giudicelli, J.F.; Berdeaux, A. Contributions of heart rate and contractility to myocardial oxygen balance during exercise. Am. J. Physiol. Heart Circ. Physiol. 2003, 284, H676-H682.
-
(2003)
Am. J. Physiol. Heart Circ. Physiol.
, vol.284
-
-
Colin, P.1
Ghaleh, B.2
Monnet, X.3
Su, J.4
Hittinger, L.5
Giudicelli, J.F.6
Berdeaux, A.7
-
38
-
-
78249274256
-
Potentially new indication of ivabradine: Treatment of a patient with postural orthostatic tachycardia syndrome
-
Hersi, A.S. Potentially new indication of ivabradine: Treatment of a patient with postural orthostatic tachycardia syndrome. Open Cardiovasc. Med. J. 2010, 4, 166-167.
-
(2010)
Open Cardiovasc. Med. J.
, vol.4
, pp. 166-167
-
-
Hersi, A.S.1
-
39
-
-
36148951151
-
Clinical results of the if current inhibition by ivabradine
-
Tardif, J.C. Clinical results of the If current inhibition by ivabradine. Drugs 2007, 67 (Suppl. 2), S36-S37.
-
(2007)
Drugs
, vol.67
, Issue.SUPPL.. 2
-
-
Tardif, J.C.1
-
40
-
-
0036628853
-
Functional characterization of subcellular localisation of hcn1 channels in rabbit retinal rod photoreceptors
-
Demontis, G.C.; Moroni, A.; Gravante, B.; Altomare, C.; Longoni, B.; Cervetto, L.; DiFrancesco, D. Functional characterization of subcellular localisation of HCN1 channels in rabbit retinal rod photoreceptors. J. Physiol. 2002, 542, 89-97.
-
(2002)
J. Physiol.
, vol.542
, pp. 89-97
-
-
Demontis, G.C.1
Moroni, A.2
Gravante, B.3
Altomare, C.4
Longoni, B.5
Cervetto, L.6
DiFrancesco, D.7
-
41
-
-
33745472240
-
Absence of direct effects of the if current blocker ivabradine on ventricular repolarization: Analysis based on a population heart rate correction formula
-
Savelieva, I.; Camm, A.J. Absence of direct effects of the If current blocker ivabradine on ventricular repolarization: Analysis based on a population heart rate correction formula. J. Am. Cardiol. 2005, 45, 1023-272.
-
(2005)
J. Am. Cardiol.
, vol.45
, pp. 1023-272
-
-
Savelieva, I.1
Camm, A.J.2
-
42
-
-
80052456261
-
Selective and specific i(f) inhibition with ivabradine: New perspectives for the treatment of cardiovascular disease
-
Ferrari, R.; Ceconi, C. Selective and specific I(f) inhibition with ivabradine: New perspectives for the treatment of cardiovascular disease. Expert. Rev. Cardiovasc. Ther. 2011, 9, 959-973.
-
(2011)
Expert. Rev. Cardiovasc. Ther.
, vol.9
, pp. 959-973
-
-
Ferrari, R.1
Ceconi, C.2
-
43
-
-
0036020147
-
Current-dependent block of rabbit sino-atrial node i(f) channels by ivabradine
-
Bucchi, A.; Baruscotti, M.; DiFrancesco, D. Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine. J. Gen. Physiol. 2002, 120, 1-13.
-
(2002)
J. Gen. Physiol.
, vol.120
, pp. 1-13
-
-
Bucchi, A.1
Baruscotti, M.2
DiFrancesco, D.3
-
44
-
-
33645513944
-
Properties of ivabradineinduced block of hcn1 and hcn4 pacemaker channels
-
Bucchi, A.; Tognati, A.; Milanesi, R.; Baruscotti, M.; DiFrancesco, D. Properties of ivabradineinduced block of HCN1 and HCN4 pacemaker channels. J. Physiol. 2006, 572, 335-346.
-
(2006)
J. Physiol.
, vol.572
, pp. 335-346
-
-
Bucchi, A.1
Tognati, A.2
Milanesi, R.3
Baruscotti, M.4
DiFrancesco, D.5
-
45
-
-
33846193702
-
Use-dependent inhibition of hhcn4 by ivabradine and relationship with reduction in pacemaker activity
-
Thollon, C.; Bedut, S.; Villeneuve, N.; Cogé, F.; Piffard, L.; Guillaumin, J.P.; Brunel-Jacquemin, C.; Chomarat, P.; Boutin, J.A.; Peglion, J.L.; Vilaine, J.P. Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity. Br. J. Pharmacol. 2007, 150, 37-46.
-
(2007)
Br. J. Pharmacol.
, vol.150
, pp. 37-46
-
-
Thollon, C.1
Bedut, S.2
Villeneuve, N.3
Cogé, F.4
Piffard, L.5
Guillaumin, J.P.6
Brunel-Jacquemin, C.7
Chomarat, P.8
Boutin, J.A.9
Peglion, J.L.10
Vilaine, J.P.11
-
46
-
-
30444452695
-
Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel
-
Milanesi, R.; Baruscotti, M.; Gnecchi-Ruscone, T.; DiFrancesco, D. Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N. Engl. J. Med. 2006, 354, 151-157.
-
(2006)
N. Engl. J. Med.
, vol.354
, pp. 151-157
-
-
Milanesi, R.1
Baruscotti, M.2
Gnecchi-Ruscone, T.3
DiFrancesco, D.4
-
47
-
-
34548655407
-
The role of heart rate in the development of cardiovascular disease
-
Reil, J.C.; Böhm, M. The role of heart rate in the development of cardiovascular disease. Clin. Res. Cardiol. 2007, 96, 585-592.
-
(2007)
Clin. Res. Cardiol.
, vol.96
, pp. 585-592
-
-
Reil, J.C.1
Böhm, M.2
-
48
-
-
77953493752
-
Correlations between progression of coronary artery disease and circulating endothelial progenitor cells
-
Briguori, C.; Testa, U.; Riccioni, R.; Colombo, A.; Petrucci, E.; Condorelli, G.; Mariani, G.; D'Andrea, D.; De, Micco, F.; Rivera, N.V.; Puca, A.A.; Peschle, C.; Condorelli, G. Correlations between progression of coronary artery disease and circulating endothelial progenitor cells. FASEB J. 2010, 24, 1981-1988.
-
(2010)
FASEB J.
, vol.24
, pp. 1981-1988
-
-
Briguori, C.1
Testa, U.2
Riccioni, R.3
Colombo, A.4
Petrucci, E.5
Condorelli, G.6
Mariani, G.7
D'Andrea, D.8
De Micco, F.9
Rivera, N.V.10
Puca, A.A.11
Peschle, C.12
Condorelli, G.13
-
49
-
-
79958267032
-
Heart rate contributes to the vascular effects of chronic mental stress: Effects on endothelial function and ischemic brain injury in mice
-
Custodis, F.; Gertz, K.; Balkaya, M.; Prinz, V.; Mathar, I.; Stamm, C.; Kronenberg, G.; Kazakov, A.; Freichel, M.; Böhm, M.; Endres, M.; Laufs, U. Heart rate contributes to the vascular effects of chronic mental stress: Effects on endothelial function and ischemic brain injury in mice. Stroke 2011, 42, 1742-1749.
-
(2011)
Stroke
, vol.42
, pp. 1742-1749
-
-
Custodis, F.1
Gertz, K.2
Balkaya, M.3
Prinz, V.4
Mathar, I.5
Stamm, C.6
Kronenberg, G.7
Kazakov, A.8
Freichel, M.9
Böhm, M.10
Endres, M.11
Laufs, U.12
-
50
-
-
44949127974
-
Chronic heart rate reduction by ivabradine prevents endothielial dysfunction in dyslipidaemic mice
-
Drouin, A.; Gendron, M.E.; Thorin, E.; Gillis, M.A.; Mahlberg-Gaudin, F.; Tardif, J.C. Chronic heart rate reduction by ivabradine prevents endothielial dysfunction in dyslipidaemic mice. Br. J. Pharmacol. 2008, 154, 749-757.
-
(2008)
Br. J. Pharmacol.
, vol.154
, pp. 749-757
-
-
Drouin, A.1
Gendron, M.E.2
Thorin, E.3
Gillis, M.A.4
Mahlberg-Gaudin, F.5
Tardif, J.C.6
-
51
-
-
19944395550
-
Two distinct pathways account for edhf-dependent dilatation in the gracilis artery of dyslipidaemic hapob+/+ mice
-
Krummen, S.; Falck, J.R.; Thorin, E. Two distinct pathways account for EDHF-dependent dilatation in the gracilis artery of dyslipidaemic hApoB+/+ mice. Br. J. Pharmacol. 2005, 145, 264-270.
-
(2005)
Br. J. Pharmacol.
, vol.145
, pp. 264-270
-
-
Krummen, S.1
Falck, J.R.2
Thorin, E.3
-
52
-
-
33846233914
-
Aging associated with mild dyslipidemia reveals that cox-2 preserves dilation despite endothelial dysfunction
-
Gendron, M.E.; Thorin-Trescases, N.; Villeneuve, L.; Thorin, E. Aging associated with mild dyslipidemia reveals that COX-2 preserves dilation despite endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2007, 292, H451-H458.
-
(2007)
Am. J. Physiol. Heart Circ. Physiol.
, vol.292
-
-
Gendron, M.E.1
Thorin-Trescases, N.2
Villeneuve, L.3
Thorin, E.4
-
53
-
-
43249091146
-
Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein e-deficient mice
-
Custodis, F.; Baumhäkel, M.; Schlimmer, N.; List, F.; Gensch, C.; Böhm, M.; Laufs, U. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Circulation 2008, 117, 2377-2387.
-
(2008)
Circulation
, vol.117
, pp. 2377-2387
-
-
Custodis, F.1
Baumhäkel, M.2
Schlimmer, N.3
List, F.4
Gensch, C.5
Böhm, M.6
Laufs, U.7
-
54
-
-
0034634281
-
Endothelial dysfunction in cardiovascular iseases: The role of oxidant stress
-
Cai, H.; Harrison, D.G. Endothelial dysfunction in cardiovascular iseases: The role of oxidant stress. Circ. Res. 2000, 87, 840-844.
-
(2000)
Circ. Res.
, vol.87
, pp. 840-844
-
-
Cai, H.1
Harrison, D.G.2
-
55
-
-
0037421492
-
Role of oxidative stress in atherosclerosis
-
Harrison, D.; Griendling, K.K.; Landmesser, U.; Hornig, B.; Drexler, H. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 2003, 91, 7A-11A.
-
(2003)
Am. J. Cardiol.
, vol.91
-
-
Harrison, D.1
Griendling, K.K.2
Landmesser, U.3
Hornig, B.4
Drexler, H.5
-
56
-
-
0033594416
-
Mcp-1 and il-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
-
Gerszten, R.E.; Garcia-Zepeda, E.A.; Lim, Y.C.; Yoshida, M.; Ding, H.A.; Gimbrone, M.A., Jr.; Luster, A.D.; Luscinskas, F.W.; Rosenzweig, A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398, 718-723.
-
(1999)
Nature
, vol.398
, pp. 718-723
-
-
Gerszten, R.E.1
Garcia-Zepeda, E.A.2
Lim, Y.C.3
Yoshida, M.4
Ding, H.A.5
Gimbrone Jr., M.A.6
Luster, A.D.7
Luscinskas, F.W.8
Rosenzweig, A.9
-
57
-
-
77956229711
-
Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in apoe-knockout mice
-
Baumhäkel, M.; Custodis, F.; Schlimmer, N.; Laufs, U.; Böhm, M. Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice. Atherosclerosis 2010, 212, 55-62.
-
(2010)
Atherosclerosis
, vol.212
, pp. 55-62
-
-
Baumhäkel, M.1
Custodis, F.2
Schlimmer, N.3
Laufs, U.4
Böhm, M.5
-
58
-
-
84856691765
-
Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress
-
Kröller-Schön, S.; Schulz, E.; Wenzel, P.; Kleschyov, A.L.; Hortmann, M.; Torzewski, M.; Oelze, M.; Renné, T.; Daiber, A.; Münzel, T. Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress. Basic Res. Cardiol. 2011, 106, 1147-1158.
-
(2011)
Basic Res. Cardiol.
, vol.106
, pp. 1147-1158
-
-
Kröller-Schön, S.1
Schulz, E.2
Wenzel, P.3
Kleschyov, A.L.4
Hortmann, M.5
Torzewski, M.6
Oelze, M.7
Renné, T.8
Daiber, A.9
Münzel, T.10
-
59
-
-
0642281745
-
T lymphocytes in atherogenesis-functional aspects and antigenic repertoire
-
de Boer, O.J.; Becker, A.E; van der Wal, A.C. T lymphocytes in atherogenesis-functional aspects and antigenic repertoire. Cardiov. Res. 2003, 60, 78-86.
-
(2003)
Cardiov. Res.
, vol.60
, pp. 78-86
-
-
De Boer, O.J.1
Becker, A.E.2
Van Der Wal, A.C.3
-
60
-
-
79251534370
-
Ivabradine reduces chemokine-induced cd4-positive lymphocyte migration
-
Walcher, T.; Bernhardt, P.; Vasic, D.; Bach, H.; Durst, R.; Rottbauer, W.; Walcher, D. Ivabradine reduces chemokine-induced CD4-positive lymphocyte migration. Mediators Inflamm. 2010, 751313.
-
(2010)
Mediators Inflamm.
, pp. 751313
-
-
Walcher, T.1
Bernhardt, P.2
Vasic, D.3
Bach, H.4
Durst, R.5
Rottbauer, W.6
Walcher, D.7
-
61
-
-
0035923479
-
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure
-
Li, D.; Shinagawa, K.; Pang, L.; Leung, T.K.; Cardin, S.; Wang, Z.; Nattel, S. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001, 104, 2608-2614.
-
(2001)
Circulation
, vol.104
, pp. 2608-2614
-
-
Li, D.1
Shinagawa, K.2
Pang, L.3
Leung, T.K.4
Cardin, S.5
Wang, Z.6
Nattel, S.7
-
62
-
-
57449102566
-
Cross-talk between mineralocorticoid and angiotensin ii signaling for cardiac remodeling
-
Di Zhang, A.; Nguyen Dinh Cat, A.; Soukaseum, C.; Escoubet, B.; Cherfa, A.; Messaoudi, S.; Delcayre, C.; Samuel, J.L.; Jaisser, F. Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling. Hypertension 2008, 52, 1060-1067.
-
(2008)
Hypertension
, vol.52
, pp. 1060-1067
-
-
Di Zhang, A.1
Nguyen Dinh Cat, A.2
Soukaseum, C.3
Escoubet, B.4
Cherfa, A.5
Messaoudi, S.6
Delcayre, C.7
Samuel, J.L.8
Jaisser, F.9
-
63
-
-
61949290852
-
Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure
-
Milliez, P.; Messaoudi, S.; Nehme, J.; Rodriguez, C.; Samuel, J.L.; Delcayre, C. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure. Am. J. Physiol. Heart Circ. Physiol. 2009, 296, H435-H441.
-
(2009)
Am. J. Physiol. Heart Circ. Physiol.
, vol.296
-
-
Milliez, P.1
Messaoudi, S.2
Nehme, J.3
Rodriguez, C.4
Samuel, J.L.5
Delcayre, C.6
-
64
-
-
78650921528
-
Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis
-
Busseuil, D.; Shi, Y.; Mecteau, M.; Brand, G.; Gillis, M.A.; Thorin, E.; Asselin, C.; Roméo, P.; Leung, T.K.; Latour, J.G.; Des Rosiers, C.; Bouly, M.; Rhéaume, E.; Tardif, J.C. Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis. Cardiology 2010, 117, 234-242.
-
(2010)
Cardiology
, vol.117
, pp. 234-242
-
-
Busseuil, D.1
Shi, Y.2
Mecteau, M.3
Brand, G.4
Gillis, M.A.5
Thorin, E.6
Asselin, C.7
Roméo, P.8
Leung, T.K.9
Latour, J.G.10
Des Rosiers, C.11
Bouly, M.12
Rhéaume, E.13
Tardif, J.C.14
|